Sunnyvale, CA, United States of America

Leah R Turner

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Leah R Turner

Introduction

Leah R Turner is a prominent inventor based in Sunnyvale, CA (US). She has made significant contributions to the field of ovarian cancer research through her innovative patents. With a total of 4 patents, her work focuses on the identification and application of ovarian-specific genes and proteins.

Latest Patents

Leah's latest patents include compositions, splice variants, and methods relating to ovarian-specific genes and proteins. These inventions involve newly identified nucleic acid molecules and polypeptides present in both normal and neoplastic ovarian cells. The patents also cover antibodies to these polypeptides, as well as agonists and antagonists. The applications of her inventions are extensive, including identifying, diagnosing, monitoring, staging, imaging, and treating ovarian cancer and non-cancerous disease states. Additionally, her work encompasses gene therapy, the production of transgenic animals and cells, and the engineering of ovarian tissue for treatment and research purposes.

Career Highlights

Throughout her career, Leah has worked with notable companies such as Diadexus, Inc. and Amersham Biosciences Corporation. Her experience in these organizations has contributed to her expertise in the field of biotechnology and cancer research.

Collaborations

Leah has collaborated with esteemed colleagues, including Yongming Sun and Chenghua Liu. These partnerships have further enhanced her research and development efforts in ovarian cancer.

Conclusion

Leah R Turner is a distinguished inventor whose work has significantly advanced the understanding and treatment of ovarian cancer. Her innovative patents and collaborations reflect her commitment to improving healthcare outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…